Roberta Lucianò1Maurizio Colecchia1,2
Francesca Sanvito1Irene Locatelli3Chiara Venegoni3Alessia Di Coste3
Davide Danilo Zani4
Angelica Stranieri4Chiara Giudice4Antonella Rigillo5Matteo Gambini5
Francesco Montorsi2,5
Andrea Salonia2,3Marco Moschini3
Massimo Alfano3*†- 1Department of Pathology, Istituto di Ricovero e Cura a Caratterle Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy
- 2Università Vita-Salute San Raffaele, Milan, Italy
- 3Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), Istituto di Ricovero e Cura a Caratterle Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy
- 4Department of Veterinary Medicine and Animal Science, University of Milan, Lodi, Italy
- 5I-Vet Diagnostica Veterinaria, Brescia, Italy
A Correction on
High-grade non-muscle invasive urothelial carcinoma in dogs and humans share specific expression of integrin α5β1
By Lucianò R, Colecchia M, Sanvito F, Locatelli I, Venegoni C, Di Coste A, Zani DD, Stranieri A, Giudice C, Rigillo A, Gambini M, Montorsi F, Salonia A, Moschini M and Alfano M (2025). Front. Oncol. 15:1590073. doi: 10.3389/fonc.2025.1590073
In the published article, there was an error in the Funding statement. “The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by funding of the Italian Ministry of Health [Ricerca corrente].” The correct Funding statement appears below.
“The author(s) declare that financial support was received for the research and/or publication of this article. This study was funded by the European Union’s Horizon EUROPE; PHIRE project is funded under grant agreement no. 101113193 (https://cordis.europa.eu/project/id/101113193). The funding source had no role in the design of this study, data interpretation, or writing of the manuscript. Views and opinions expressed are those of the author(s) and do not necessarily reflect those of the EU or the EIC.”
The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: urothelial cancer, human, dog, integrin, marker, bladder
Citation: Lucianò R, Colecchia M, Sanvito F, Locatelli I, Venegoni C, Di Coste A, Zani DD, Stranieri A, Giudice C, Rigillo A, Gambini M, Montorsi F, Salonia A, Moschini M and Alfano M (2025) Correction: High-grade non-muscle invasive urothelial carcinoma in dogs and humans share specific expression of integrin α5β1. Front. Oncol. 15:1640082. doi: 10.3389/fonc.2025.1640082
Received: 03 June 2025; Accepted: 06 June 2025;
Published: 25 June 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Lucianò, Colecchia, Sanvito, Locatelli, Venegoni, Di Coste, Zani, Stranieri, Giudice, Rigillo, Gambini, Montorsi, Salonia, Moschini and Alfano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Massimo Alfano, YWxmYW5vLm1hc3NpbW9AaHNyLml0
†ORCID: Massimo Alfano, orcid.org/0000-0002-6904-9158